share_log
Benzinga ·  Mar 28 11:20
60 Degrees Pharmaceuticals Says FY 2024 Net Product Revenues Increased 140% To $607,6000 On Growth From Domestic Commercial Sales Of ARAKODA
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 250

Recommended

Write a comment